Literature DB >> 23470624

Short palate, lung, and nasal epithelial clone-1 is a tightly regulated airway sensor in innate and adaptive immunity.

Clemente J Britto1, Qing Liu, David R Curran, Bhargavi Patham, Charles S Dela Cruz, Lauren Cohn.   

Abstract

Short palate, lung, and nasal epithelial clone-1 (SPLUNC1) is a protein abundantly expressed by the respiratory epithelium of the proximal lower respiratory tract, a site of great environmental exposure. Previous studies showed that SPLUNC1 exerts antimicrobial effects, regulates airway surface liquid and mucociliary clearance, and suppresses allergic airway inflammation. We studied SPLUNC1 to gain insights into its role in host defense. In the lower respiratory tract, concentrations of SPLUNC1 are high under basal conditions. In models of pneumonia caused by common respiratory pathogens, and in Th1-induced and Th2-induced airway inflammation, SPLUNC1 secretion is markedly reduced. Pathogen-associated molecular patterns and IFN-γ act directly on airway epithelial cells to inhibit SPLUNC1 mRNA expression. Thus, SPLUNC1 is quickly suppressed during infection, in response to an insult on the epithelial surface. These experiments highlight the finely tuned fluctuations of SPLUNC1 in response to exposures in the respiratory tract, and suggest that the loss of SPLUNC1 is a crucial feature of host defense across air-breathing animal species.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470624      PMCID: PMC3727874          DOI: 10.1165/rcmb.2012-0072OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  47 in total

1.  Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung.

Authors:  W M Weston; E E LeClair; W Trzyna; K M McHugh; P Nugent; C M Lafferty; L Ma; R S Tuan; R M Greene
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Topographical continuity of bacterial populations in the healthy human respiratory tract.

Authors:  Emily S Charlson; Kyle Bittinger; Andrew R Haas; Ayannah S Fitzgerald; Ian Frank; Anjana Yadav; Frederic D Bushman; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2011-06-16       Impact factor: 21.405

3.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury.

Authors:  Xuchen Zhang; Peiying Shan; Salman Qureshi; Robert Homer; Ruslan Medzhitov; Paul W Noble; Patty J Lee
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

5.  IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.

Authors:  X F Bai; J Zhu; G X Zhang; G Kaponides; B Höjeberg; P H van der Meide; H Link
Journal:  Clin Immunol Immunopathol       Date:  1997-05

6.  Quantitation of SPLUNC1 in saliva with an xMAP particle-based antibody capture and detection immunoassay.

Authors:  Karl G Kohlgraf; Abbey R Ackermann; Kindra K Burnell; Rupasree N Srikantha; Sophie A Joly; Jennifer A Bartlett; Lokesh Gakhar; Georgia K Johnson; Paul B McCray; Janet M Guthmiller; Kim A Brogden
Journal:  Arch Oral Biol       Date:  2011-09-16       Impact factor: 2.633

7.  SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype.

Authors:  Lynne Bingle; Simon S Cross; Alec S High; William A Wallace; Deirdre A Devine; Suzanne Havard; Michael A Campos; Colin D Bingle
Journal:  J Pathol       Date:  2005-03       Impact factor: 7.996

8.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

Authors:  O Adachi; T Kawai; K Takeda; M Matsumoto; H Tsutsui; M Sakagami; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-07       Impact factor: 31.745

10.  Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production.

Authors:  L Cohn; R J Homer; A Marinov; J Rankin; K Bottomly
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  11 in total

Review 1.  Bactericidal/Permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease.

Authors:  Clemente J Britto; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

2.  BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation.

Authors:  Clemente J Britto; Naiqian Niu; Sara Khanal; Luai Huleihel; Jose D Herazo-Maya; Alison Thompson; Maor Sauler; Martin D Slade; Lokesh Sharma; Charles S Dela Cruz; Naftali Kaminski; Lauren E Cohn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

3.  SPLUNC1 is a negative regulator of the Orai1 Ca2+ channel.

Authors:  Tongde Wu; Alexandra S Goriounova; Erin N Worthington; Joe A Wrennall; Arunava Ghosh; Saira Ahmad; M Flori Sassano; Robert Tarran
Journal:  Physiol Rep       Date:  2022-05

4.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production.

Authors:  April Kalinowski; Iris Ueki; Gundula Min-Oo; Eric Ballon-Landa; David Knoff; Benjamin Galen; Lewis L Lanier; Jay A Nadel; Jonathan L Koff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-16       Impact factor: 5.464

6.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

7.  Association of innate defense proteins BPIFA1 and BPIFB1 with disease severity in COPD.

Authors:  Elise G De Smet; Leen Jm Seys; Fien M Verhamme; Bart M Vanaudenaerde; Guy G Brusselle; Colin D Bingle; Ken R Bracke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-19

8.  Gammaherpesvirus infection modulates the temporal and spatial expression of SCGB1A1 (CCSP) and BPIFA1 (SPLUNC1) in the respiratory tract.

Authors:  Gail H Leeming; Anja Kipar; David J Hughes; Lynne Bingle; Elaine Bennett; Nathifa A Moyo; Ralph A Tripp; Alison L Bigley; Colin D Bingle; Jeffery T Sample; James P Stewart
Journal:  Lab Invest       Date:  2014-12-22       Impact factor: 5.662

9.  Investigation of anti-infection mechanism of lactoferricin and splunc-1.

Authors:  Yung An Tsou; Hung-Jin Huang; Wesley Wen Yang Lin; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

10.  An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection.

Authors:  K M Akram; N A Moyo; G H Leeming; L Bingle; S Jasim; S Hussain; A Schorlemmer; A Kipar; P Digard; R A Tripp; R V Shohet; C D Bingle; J P Stewart
Journal:  Mucosal Immunol       Date:  2017-05-17       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.